Pegloticase 8MG/ML IMJ/soln

Ended Awarded

Contract number
36C26023F0055
Awardee
Awarding agency
Obligated
$49,676

Award facts

Contract value 100% obligated
$49,676.16 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Seattle, WA 98108, USA

Award details come from SAM.gov/FPDS.

About this award

Horizon Therapeutics USA Inc. was awarded a $49,676.16 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The firm fixed price order is for the delivery of PEGLOTICASE 8MG/ML IMJ/SOLN to Seattle, Washington by December 31, 2022. No set-aside designation was applied to this order placed under GSA Schedule FSS-61-IB for pharmaceutical products and placed by the VHA to support healthcare services for veterans in the Pacific Northwest region.

Quick answers

Who was awarded contract 36C26023F0055?

36C26023F0055 was awarded to Horizon Therapeutics Usa, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on November 3, 2022.

How much is contract 36C26023F0055 worth?

The government has obligated $49,676 on 36C26023F0055.

Is contract 36C26023F0055 an order under another contract?

Yes. 36C26023F0055 is a delivery order under 36F79719D0224, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26023F0055 competed?

The extent of competition for 36C26023F0055 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award